Afuco™ Anti-Human RSPO3 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-RSPO3 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. Anti-RSPO3 is the first drug in its class to target the R-spondin-LGR pathway, and has shown robust preclinical activity against a number of solid tumor types.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-726CL |
| Pricing | Inquiry |
| Type | ADCC enhanced antibody |
| Storage | Store at -20°C. Avoid multiple freeze/thaw cycles. |
| Target | RSPO3 |
| Species Reactivity | Human |